Early-Age Onset CRC International Symposium
On June 11th at 11a-1:30p Eastern time (17:00 European time) Fight Colorectal Cancer and the medical community from the Jiménez Díaz Foundation Hospital in Madrid, Spain will be virtually co-hosting the 2nd annual Early-Age Onset Colorectal Cancer International Symposium. As EAO CRC has been on the rise, it’s necessary to convene together global leaders in the field to bring attention to the rise in cases and understand the causes of these striking increases. We will spend time discussing the current burden of EAO CRC and explore a collaborative path forward.
Your registration is important – even if you can’t attend live, we’ll share the slides and video recording of the presentation directly to you!
Check out the Featured Speakers!
Dr. Jose Perea, MD, PhD
Dr. Perea is a Consultant Surgeon of the Surgery Department, and Principal Investigator of the Research Institute at the Fundación Jiménez Díaz University Hospital, Madrid, Spain. He is a board member of the World Journal of Gastroenterology and a member of the Board of the Spanish Association of Coloproctology (AECP) as well as Member of Fight CRC’s Medical advisory board and Founding Member of the Colon Cancer Foundation’s Integrated Medical advisory committee. His main area of interest is clinical and translational understanding of colorectal cancer (CRC) subtypes, such as Early Onset colorectal cancer (EAOCRC), multiple primary CRCforms, CRC hereditary conditions, and inflammatory Bowel Diseaseassociated CRC. He has co-authored more than 100 scientific publications in national and international journals. He is director of the Early-Onset Colorectal Cancer International Symposium and is leading coordinator of the European study of EOCRC (EUREOC) group and a worldwide network for the study of the same type of CRC.
Ms. Andrea (Andi) Dwyer of the University of Colorado Cancer Center is an advisor to Fight Colorectal Cancer, a national nonprofit, in their health promotion and research aims focused on the colorectal cancer community. Andi is the director and a founding member of the Colorado Cancer Screening Program (CCSP) at the University of Colorado Cancer Center and implemented the country’s largest screening patient navigation program for preventive screening within the safety net clinics of Colorado. Dwyer serves as co-investigator on various practice-based research and implementation science initiatives, funded by CDC and NCI. At the state level, Ms. Dwyer is on the Executive Committee of the Patient Navigator Alliance and Chair of the Colorado Cancer Coalition and is the Vice-Chair of the American Cancer Society’s National Patient Navigation Roundtable.
Dr. Francesc Balaguer, MD, PhD
Head of the Gastroenterology Department at the Hospital Clinic of Barcelona since 2016, and Director of the High-Risk Colorectal Cancer Clinic since 2006. His main area of interest is clinical and translational understanding of high-risk colorectal cancer conditions, including hereditary syndromes. He is a board member of the United European Gastroenterology (National Societies Committee, UEG), Secretary-General of the Spanish Gastrointestinal Association (AEG), and Editor of Gastroenterologia y Hepatologia (Elsevier). He is an investigator of the research group “Gastrointestinal and pancreatic oncology group” at IDIBAPS and CIBEREHD. He has co-authored more than 210 scientific publications in international journals with more than 4480 citations. He has an h-index 32 (SCOPUS).
Heather Hampel, MS, LGC
Heather Hampel completed her Bachelor of Science degree in Molecular Genetics at the Ohio State University in 1993. She attained her Master’s degree in Human Genetics from Sarah Lawrence College in 1995. She received certification from the American Board of Genetic Counseling in 1996. She worked as a cancer genetic counselor at Memorial Sloan- Kettering Cancer Center before moving to The Ohio State University Comprehensive Cancer Center (OSUCCC) in 1997.
Currently, Heather is a Professor in the Department of Internal Medicine and Associate Director of the Division of Human Genetics. She is also the Associate Director of biospecimen Research for the OSUCCC. She was the study coordinator for the Columbus-area Lynch syndrome study which determined the frequency of Lynch syndrome among newly diagnosed patients with these cancers. This study culminated in first author publications in the New England Journal of Medicine in May of 2005, Cancer Research in August of 2006, and the Journal of Clinical Oncology in December of 2008. She is now the PI of the Ohio Colorectal Cancer Prevention Initiative which is screening colorectal cancer patients from 50 hospitals throughout the state for hereditary cancer syndromes. The first major publication from that study showing that 16% of early-onset colorectal cancers are hereditary was published in 2017 in JAMA Oncology. Heather Hampel was the Region IV Representative on the Board of Directors of the National Society of Genetic Counselors in 2003-4. She was on the Board of Directors for the American Board of Genetic Counseling from 2006-2011, serving as President in 2009 and 2010. She was elected to the Steering Committee member of the National Colorectal Cancer Roundtable in 2016. She has been on the Council of the Collaborative Group of the Americas on Inherited Colorectal Cancer since 2016 and served as President in 2018.
Rebecca Siegel, MPH
Rebecca Siegel has been a descriptive epidemiologist at the America Cancer Society in Atlanta for the past 15 years and is currently Scientific Director of Surveillance Research. In addition to leading the annual Cancer Statistics article, she oversees the production of eight Facts & Figures educational reports and publishes scientific articles across the cancer continuum to help inform evidence-based cancer prevention and control worldwide. Her primary. research interest is disparities in colorectal cancer occurrence with a focus on early-onset CRC. Since 2009, she has published numerous articles characterizing the epidemiology of early-onset colorectal cancer to provide clues about what might be causing the increasing trend, including the first report of a strong birth cohort effect implicating behavioral factors.
Reese Garcia, MPH
Reese joined Fight CRC in August of 2017 as the Research Advocacy Manager. She is passionate about working with cancer survivors and those that empower survivors. She currently oversees the Research Advocacy Training and Support (RATS) program and helps plan and coordinate colorectal cancer research related campaigns nationwide. Reese earned her Master of Public Health at the Colorado School of Public Health at the University of Colorado Denver and spent a majority of her time working with disadvantaged global and rural communities to overcome health disparities. Currently Reese lives in Denver, Colorado.
Antonino Spinelli, MD, PhD, FASCRS
Prof. Antonino Spinelli leads the Unit of Colon and Rectal Surgery of Humanitas Research Hospital, Rozzano, Milan, Italy, and is a Full Professor of Surgery at Humanitas University. He is Associate Editor for Colorectal Disease, Diseases of the Colon and Rectum, JARC, and Editorial Board Member for the Journal of Crohn’s Colitis, for Coloproctology and for Updates in Surgery. He is a member of the Scientific Program Committee of ESCP, Assistant Secretary of ESCP, Member of the Guidelines Committee of ECCO. He has authored/co-authored more than 185 Pubmed indexed papers, with an IF > 860 and an H Index of 37.
Richard Hayes, DDS, MPH, PhD, Professor
Dr. Richard B. Hayes, Professor of Epidemiology, NYU School Medicine, carries out research on the genetic and environmental determinants of colorectal cancer. His research focuses on prediction of colorectal cancer risk, with a particular emphasis on investigations to better understand the developing epidemic worldwide in early-onset (<50 years of age) colorectal cancer.
Damían García Olmo, MD, PhD
Damian Garcia-Olmo is currently Full Professor of Surgery at the Autonomous University of Madrid (UAM) and Head of the Department of Surgery at the University Hospital Fundación Jiménez Díaz; (Madrid, Spain).
As a surgeon he has a special focus on Colorectal Cancer and Proctology with a broad experience along more than 8,000 procedures. A pioneer in the clinical use of stem cells associated to Minimally Invasive Surgery techniques, the group has developed a complete line of clinical trials with MSCs derived from adipose tissue. Dr. Garcia-Olmo is the author of a number of patents in Regenerative Medicine. The research team, consisting of surgeons, biologist and veterinarian, has extensive experience in experimental models and has participated in more than 30 clinical trials. His research activity is reflected in high impact scientific publications: More than 200 scientific papers indexed with more than 6,000 citations with 35 H index. Past Editor-in-Chief of the “Word Journal of Gastroenterology”.
Dr. Rogelio González Sarmiento, MD, PhD
Dr. Rogelio González Sarmiento graduated and received his doctorate from the University of Salamanca in 1979 and 1985 respectively. He specialized in Hematology and Hemotherapy in 1985. From 1985 until he obtained the position of full professor of the area of knowledge of Medicine in 1989, he received numerous scholarships. He has worked in the study of genetic rearrangements and characterization of chromosomal translocations in hematological malignancies and, later in the cloning and characterization of new genes involved in tumorigenesis.
Read Dr. González Sarmiento’s full bio here:
Dr. Miguel Urioste Azcorra, MD
Miguel Urioste graduated in Medicine from the Universidad de Sevilla, and obtained his Ph.D. degree by the Universidad Complutense de Madrid in 1992. He was in charge of the Clinical and Cytogenetics Unit of the Spanish Registry of Birth Defects of Instituto de Salud Carlos III. Here he worked on the clinical and genetic research of developmental defects. In 1998 he joined the Genetics Department at the Universidad Autónoma de Madrid to study on the molecular characterization of mice thymic lymphomas. In 1999 he moved to the Genetics Service of the Fundación “Jiménez Díaz” (Madrid) to work on the cytogenetic study of haematological neoplasias and to work on the familial and hereditary cancer syndrome field. In May 2000 he went to the CNIO as a researcher in the Human Cancer Genetics Programme. Currently, he is responsible of the Familial Cancer Clinical Unit and his work is focused in both hereditary and early-onset forms of colorectal cancer and in other less frequent syndromes of genetic predisposition to cancer.